<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03705364</url>
  </required_header>
  <id_info>
    <org_study_id>18124</org_study_id>
    <nct_id>NCT03705364</nct_id>
  </id_info>
  <brief_title>Fall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MS</brief_title>
  <acronym>iRoll</acronym>
  <official_title>Validation of a Fall Prevention Program Among Non-Ambulatory Wheeled Mobility Device Users With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Urbana-Champaign</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Urbana-Champaign</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A research study to examine the effectiveness of a fall management program to prevent falls
      and develop fall recovery strategies for wheeled mobility device users living with Multiple
      Sclerosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Falls are a serious concern for wheelchair and scooter users with Multiple Sclerosis (MS).
      Approximately 75% of the population reports at least one fall in a 6-month period and nearly
      half report frequent falls. Falls can result in physical injuries and contribute to activity
      curtailment. Despite the negative consequences, limited evidenced-based fall prevention
      programs designed specifically for wheelchair and scooter users with MS exist.

      Recognizing the threat falls pose to health and well-being and the dearth of fall prevention
      programs, the purpose of this study to perform a structured process evaluation and examine
      the feasibility and efficacy of a community-based intervention specifically designed to
      reduce fall incidence among wheelchair and scooter users with MS. Secondary aims of the
      intervention are to improve functional mobility skills associated with fall risk (e.g.
      transfer and wheelchair skills, balance), increase knowledge of fall risk factors, decrease
      fear of falling and enhance quality of life and community participation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in fall incidence</measure>
    <time_frame>44 weeks</time_frame>
    <description>Fall Diary; Construct: to report and track the number of falls experienced; Less number of falls indicates better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Management of Fall</measure>
    <time_frame>44 weeks</time_frame>
    <description>Fall Management Scale (FMS); Construct: to measure the perceived ability to manage risk of falls or actual falls; Scale range: 5 - 45, higher scores indicate lower degree of confidence; Items are summed to get the final score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevention of Fall</measure>
    <time_frame>44 weeks</time_frame>
    <description>Falls Prevention Strategies Survey (FPSS); Construct: to measure the use of fall prevention strategies; Scale range: 0 - 22, higher scores reflect more regular use of more fall prevention strategies; Never do: 0, Do sometimes: 1, Do regularly: 2; Items are summed to get the final score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevention and Management of Fall</measure>
    <time_frame>44 weeks</time_frame>
    <description>Falls Prevention and Management Questionnaire (FPMQ); Construct: to measure the ability to prevent and manage falls; Scale range: 0 - 48, higher scores indicate higher ability to prevent and manage falls; Items are scored from 0 (&quot;strongly disagree&quot;) to 4 (&quot;strongly agree&quot;); Items are summed to get the final score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Wait List Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait list control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fall Management program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fall Management program</intervention_name>
    <description>Comprehensive fall management program that develops strategies for non-ambulatory wheelchair users living with MS to develpo strategies to recover from a fall.</description>
    <arm_group_label>Fall Management program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of Multiple Sclerosis

          2. &gt;18 years old

          3. Main form of mobility is via a wheeled mobility device (Patient Determined Disease
             Steps Level 7)

          4. Self reported ability to transfer with moderate assistance or less

          5. Self-reported fall history (at least 1 fall/12 months)

        Exclusion Criteria:

          1. MS exacerbation in the past 30 days

          2. Received a score of 10 or above to the Short Blessed Test (attached)

          3. Inability to sit upright for at least 1 hour.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura A Rice, PhD,MPT,ATP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Kinesiology and Community Health, College of Applied Health Sciences, University of Illinois at Urbana-Champaign</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emily Pike, MPH</last_name>
    <phone>217-244-7006</phone>
    <email>dpqoluiuc@outlook.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Shepherd Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Moldavskiy</last_name>
      <phone>404-350-7655</phone>
      <email>marina_moldavskiy@shepherd.org</email>
    </contact>
    <investigator>
      <last_name>Deborah Backus, PhD, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UIC</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Pike</last_name>
      <phone>217-244-7006</phone>
      <email>dpqoluiuc@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Elizabeth W Peterson, PhD,OTR/L</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Toni Van Denend, MS,OTR/L</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UIUC</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Pike</last_name>
      <phone>217-244-7006</phone>
      <email>dpqoluiuc@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Laura A Rice, PhD,MPT,ATP</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>JongHun Sun, MS, ATC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca Yarnot, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Libak Abou, MS, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacob J Sosnoff, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sa Shen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wheelchair</keyword>
  <keyword>non-ambulatory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individuals participant data will not be available to other researchers.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT03705364/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

